Dr Michael Lange and Fortifeye Vitamins will launch 2 new sports nutrition supplements under the Fortifeye Performance Nutrition label by November 2019 . Dr Michael Lange wanted to develop the ultimate muscle fuel that will be based on the latest evidence based science and have all natural flavor system and sweeteners. Dr Lange states there is amazing science proving that the right combination of nutrients will enhance muscle synthesis, muscle growth, strength and endurance . Fortifeye Fit is the first new generation sports nutrition supplement that can be used as both pre and post workout fuel . Dr Lange also developed an extremely pure non denatured whey protein isolate that can be used as a stack in combination with Fortifeye Fit to enhance your workouts that much more. Fortifeye Fit and Fortifeye Grass Fed Whey Isolate were made to be used alone or together to improve the outcomes of your hard work. Coming very soon! Dr Michael Lange calls Fortifeye Fit , the ultimate muscle fuel! Dr Lange has hired Richard (Doc) Hall PHD to be director of the Lange Nutrition Center in Ocala and to help launch the new Fortifeye Performance Nutrition line. Doc Hall is an industry leader in the sports nutrition arena.
Dr. Michael Lange and Fortifeye Vitamins researches and develops new Grass Fed Whey Protein Isolate.
Fortifeye Grass Fed Whey Isolate is the best non denatured whey protein isolate to be under the Fortifeye Performance Nutrition label . It is one of the only unflavored, unbleached, undenatured, grass fed, American Cow, micro filtered, cold pasteurized whey protein isolate available. The process of purification, concentration And pasteurization keeps the delicate proteins and amino acids in tact and bioavailable. The milk has gone thru a cold pasteurization process using 72 degrees Celsius for only 15 seconds this keeps the protein bioavailability at the highest level possible. Ultra and micro filtration is used to eliminate fat, cholesterol, casein and lactose without denaturing the protein. Most protein isolates you buy today are from cows fed growth hormone, GMO grain, antibiotics and then pasteurized under high heat for extended periods of time and then acid is used that further denature the protein. Fortifeye Grass Fed Whey Isolate uses the highest quality milk and the very latest most natural technology in the formulation process that preserves the bio availability of the proteins. This protein isolate mixes very easily and completely in a shaker cup and there is no need to use a blender. Fortifeye Grass Fed Whey protein can be used alone or for maximum muscle synthesis should be added to Fortifeye Fit as The ultimate muscle fuel. This protein has zero carbohydrates and zero sugar so perfect for keto or low carb diets!
Give your body the fuel it thirsts for! Dr Michael Lange has been involved in research and development of a new supplement called Fortifeye Fit for many years. This new powdered supplement will take the very latest in evidence based science in sports nutrition and combine it into one supplement. Fortifeye FIT will be used as a pre, intra and post workout supplement. This supplement is being developed to maximize your training by enhancing muscle synthesis, endurance and strength. This will be all natural with no artificial dyes, sweeteners, flavoring agents or caragenaneen . Fortifeye Fit will be a combination of 10 evidence based nutrients that when combined will give the athlete in the gym or on the court that needed edge. This new generation supplement will enable the user to maximize the benefits of hard training. People will see much faster gains in strength , muscle size and endurance when Fortifeye Fit is combined with training . This supplement will give the nutrients necessary for explosive energy and prolonged energy while reducing recoverytime and enhancing muscle synthesis. Look for availability around end of September 2019. This new supplement will go under the Fortifeye Perfomance Nutrition brand. Fortifeye Grass Fed Whey Isolate Protein is also under development now to be used in conjunction with Fortifeye fit As a Post workout supplement stack. Fortifeye Whey Protein Isolate will be a unique whey protein isolate that has much higher levels of the critical branch chain amino acid s for muscle building . This new generation Grass Fed Whey Protein will be a non denatured grass fed micro filtered whey isolate. A unique patented cold filtration process is utilized to purify and concentrate the grass fed milk without using harsh chemicals or high heat. This keeps the delicate proteins and amino acids intact and much more bio available. This new Protein will work in synergy with the new Fortifeye Fit in aiding muscle synthesis, strength , recovery and endurance. This will be available by September 2019. Now Fortifeye will have 2 Protein options ; Fortifeye Super Protein and Fortifeye Grass Fed Whey Isolate. These combinations will be the ultimate in muscle fuel .
Dr Lange and Zoom Essence worked hard on the flavors of Fortifeye Fit . This was a very difficult task to make this supplement have a good flavor using all natural ingredients. As of late August, 3 flavors Fortifeye are considering for the Fortifeye Fit are Fruit punch , strawberry watermelon and berry flavor.
Fortifeye Super Omega 3 MAX has been developed after years and years of research . This is one of the most potent and purest omega 3 fish oils available in the world today. This omega 3 supplement is purified and concentrated in a state of the art facility in Norway . This new technology allows for more EPA and DHA in the same size capsule as the original Fortifeye Super Omega. This new omega 3 max will allow for much better compliance since the high dosage of omega three can be delivered with less capsules . Fortifeye Super Omega MAX will be 50% more potent than Fortifeye Super Omega and retails for only $35 . This new omega is more concentrated and less expensive that most competitors . A lot of new science is proving the need for at least 1000 mg of EPA and high dosing of DHA (500-900) Is necessary to help many health issues that effect the eyes, heart, brain , skin, joints ,muscles and much more . Fortifeye super omega 3 Max has 1200 mg of EPA and 900 mg of DHA per dosage!! Start to gain the amazing health benefits of the correct form of omega 3 . Order Fortifeye Super Omega Max today. This new formulation of omega 3 will also be beneficial to athletes especially when combined with the soon to be released Fortifeye Fit .
Supporting Articles & Publications
Degenerative rotator cuff tears are associated with a low Omega-3 Index
Patients with full thickness degenerative rotator cuff tears had a significantly lower Omega-3 Index than controls without rotator cuff tendinopathy. Whether a lower Omega-3 Index represents an independent risk factor for degenerative rotator cuff tears should be further investigated, e.g. in a longitudinal study.
A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk
Objective: To conduct meta-analyses of randomized controlled trials (RCTs) to estimate the effect of eicosapentaenoic and docosahexaenoic acid (EPAþDHA) on coronary heart disease (CHD), and to conduct meta-analyses of prospective cohort studies to estimate the association between EPAþDHA intake and CHD risk.
Peet,Malcolm; Stokes, Caroline Omega-3 fatty acids in the treatment of psychiatric disorders Drugs 2005;65:1051-1059 The importance of omega-3 fatty acids for physical health is now well recognised and there is increasing evidence that omega-3 fatty acids may also be important to mental health. The two main omega-3 fatty acids in fish oil, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have important biological functions in the CNS. DHA is a major structural component of neuronal membranes, and changing the fatty acid composition of neuronal membranes leads to functional changes in the activity of receptors and other proteins embedded in the membrane phospholipid. EPA has important physiological functions that can affect neuronal activity. Epidemiological studies indicate an association between depression and low dietary intake of omega-3 fatty acids, and biochemical studies have shown reduced levels of omega-3 fatty acids in red blood cell membranes in both depressive and schizophrenic patients.Five of six double-blind, placebo-controlled trials in schizophrenia, and four of six such trials in depression, have reported therapeutic benefit from omega-3 fatty acids in either the primary or secondary statistical analysis, particularly when EPA is added on to existing psychotropic medication. Individual clinical trials have suggested benefits of EPA treatment in borderline personality disorder and of combined omega-3 and omega-6 fatty acid treatment for attention-deficit hyperactivity disorder. The evidence to date supports the adjunctive use of omega-3 fatty acids in the management of treatment unresponsive depression and schizophrenia. As these conditions are associated with increased risk of coronary heart disease and diabetes mellitus, omega- 3 fatty acids should also benefit the physical state of these patients. However, as the clinical research evidence is preliminary, large, and definitive randomised controlled trials similar to those required for the licensing of any new pharmacological treatment are needed
People with DES complains most frequently of a scratchy or foreign body sensation. Redness, pain, itching, inability to produce tears, light sensitivity, and blurred vision with difficulty driving after dark are common symptoms. The symptoms are located mainly to the pain sensitive cornea.
Recent animal experiments have demonstrated that DES is not exclusively a disease located to the cornea since inflammatory cells and immunological chemical mediators were found in the tear fluid. Since cornea does not contain tissue engaged in an inflammatory process the lacrimal gland and the conjunctiva have to participate in the syndrome even though symptoms relate to cornea.
A number of controlled clinical studies have been published where these fatty acids have been given in a placebo-controlled design. Rahul Bhargava and colleagues (1) included 264 DES subjects given 1g daily of marine omega3 fatty acids mainly eicosapentaenoic acid (EPA) and compared effects on symptoms, tear production and corneal cell integrity. A large control group of 254 individuals were given matching placebo. After three months, there was a significant reduction in symptom score in the omega3 group along with improvement in tear production and corneal cell integrity. Kawatita K et al (2) included 27 DES patients in a study providing half of the group with a product containing 1.3g of EPA and 0,5 g of docosahexaenoic acid (DHA) daily for 12 weeks. Symptoms were significantly reduced in the intervention group.
Kangari H and collaborators included sixty-four patients with dry eye symptoms (3). The subjects were randomized into two groups: 33 persons in the treatment group given 2 capsules of omega-3 (each containing 180 mg EPA and 120 mg DHA and 31 persons in the placebo group. The tear break-up time (TBUT), Schirmer’s score, and Ocular Surface Disease Index (OSDI) were measured 1 month after the intervention. Repeated-measures analysis of variance showed that improvements in TBUT, OSDI, and Schirmer’s scores were significantly better in the treatment group than in the placebo group. The changes in the treatment and placebo groups were 71% and 3.3% for TBUT (P<0.001), 26% and 4% (P=0.004) for dry eye symptoms, and 22.3% and 5.1% for Schirmer’s score (P=0.033), respectively. In conclusion, his study demonstrated that omega-3 fatty acids for 30 days was associated with a decrease in the rate of tear evaporation, an improvement in dry eye symptoms, and an increase in tear secretion.
In another study by Bhargava R and Kumar P 496 contact lens carriers with DES were randomly allocated to treatment with marine omega3 fatty acids (0.6g daily) or placebo for six months (4). The study demonstrated a significant improvement in dry eye symptoms and an increase in tear secretion in the omega3 treated group. The Bhargava group included 428 computer workers with DES in another study (5). Half the group were given the same dose of omega3 fatty acids as in study 7. The rest were provided with matching placebo capsules and followed for three months. There was a significant improvement in symptoms followed by increased tear production in the active treatment group. A recent study by Bhargava R and collaborators evaluated the effect of higher omega 3 fatty acid dose than in their previous studies namely 2,400 mg/day for 45 days on dry eye symptoms, tear production, stability, and conjunctival cytology in young and middle-aged visual display terminal (VDT) users (6). It was a randomized, double-blind, interventional study where 256 VDT users were randomized to receive omega-3 while 266 subjects received matching placebo capsules. Patients were evaluated at baseline, 30 days, and 45 days. The primary outcome measure was an improvement in dry eye symptoms. Secondary outcome measures were improvement in the Nelson grade on conjunctival impression cytology, Schirmer test values, and tear film breakup time (TBUT). In the omega3 group, the mean symptom score differed significantly between active treatment and placebo (P<0.005) as did the TBUT and Nelson grade evaluation. Schirmer test values did not differ significantly after adjustment for multiple comparisons. Consumption of 2,400 mg/day of O3FA supplement improved symptoms, tear stability, and conjunctival cytology but not tear production in symptomatic VDT users.
In a meta-analysis of published studies using a randomized, placebo-controlled design, Liu A and Yi J included a total of 790 participants in seven independent studies published between 2007 and 2013 (8). The authors concluded that based on the experience from these studies Omega3 fatty acid seemed to offer an effective therapy for DES.
Bhargava R, Kumar P, Kumar M, et al.A randomized controlled trial of omega-3 fatty acids in dry eye syndrome. International journal of ophthalmology 2013;6(6): 811-816
Kawakita T, Kawabata F, Tsuji T et al. Effects of dietary supplementation with fish oil on dry eye syndrome subjects: randomized controlled trial. Biomedical research 2013;34(5):215-220
Kangari H, Eftekhari MH, Sardari S et al. Short-term consumption of oral omega-3 and dry eye syndrome. Ophthalmology 2013;120(11):2191-2196
Bhargava R and Kumar P. Oral omega-3 fatty acid treatment for dry eye in contact lens wearers. Cornea 2015;34(4):413-420
Bhargava R, Kumar P, Phogat H et al. Oral omega-3 fatty acids treatment in computer vision syndrome related dry eye. Contact lens & anterior eye 2015;38(3):206-210
Bhargava R, Kumar P, and Arora Y. Short-Term Omega 3 Fatty Acids Treatment for Dry Eye in Young and Middle-Aged Visual Display Terminal Users. Eye & contact lens 2016;42: 231-236
The Dry Eye Assessment and Management Study Research Group. n−3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease; The DREAM study. New England J of Med 2018 April 13.
Liu A and Ji J. Omega-3 essential fatty acids therapy for dry eye syndrome: a meta-analysis of randomized controlled studies. Medical science monitor 2014;20:1583-1589
Article below posted on the European Journal of Clinical Nutrition website.
Association of blood levels of marine omega-3 fatty acids with coronary calcification and calcium density in Japanese men
Clinical trials of eicosapentaenoic acid (EPA) among high-risk groups in Japan in which consumption of mairne-omega-3 fatty acids (OM3) is much higher than other countries showed slower progression of coronary atherosclerosis. We aimed to determine the cross-sectional associations of coronary artery calcification (CAC) and calcium density with OM3, EPA, and docosahexaenoic acid (DHA), two principal OM3, in the general population in Japan.
Newest most concentrated and purified Omega Three Fish Oil by Fortifeye®
High Potency/Triple Strength 900 EPA/600 DHA
Best value in the industry for triglyceride form omega-3
Now available Fortifeye Super omega 3 MAX an EPA of 1200 and DHA of 900 in 2 gel caps. This is one of the most potent omega 3 fish oils in triglyceride form available . New emerging science is proving that an EPA of at least 1000 mg is necessary for many diseases like dry eye syndrome. Fortifeye Super Omega 3 Max is one of the only omega 3 supplements with higher than theses levels per dose. Many new studies also show that omega 3 in these dosages is beneficial for muscle recovery in athletes. Athletes will benefit dramatically from consuming this type of omega 3 when combined with a new supplement being developed by Dr Michael Lange and Fortifeye Vitamins called Fortifeye Fit. Fortifeye Fit should be available in August or September 2019.
Natural Triglyceride Form • Molecularly Distilled for Maximum Purity Natural Orange/ Lemon Flavor • Pharmaceutical Grade
Heart Health • Brain Health • Eye Health • Joint Health • Circulation • Good Blood Pressure • Healthy Cholesterol • Improved Triglycerides • Skin, Hair & Nail Health • Mental & Cognitive Health
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.